Company Profile
Twist Bioscience Corporation Stock Price, News & Analysis
- Ticker:
- TWST
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Twist Bioscience is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
85.00 USD (-0.20%)
Close
Last updated: June 23, 2026 at 00:00
5.29B USD
Market cap
Why the stock is moving
TWST is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Twist Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Twist Bioscience is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Twist Bioscience follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Twist Bioscience sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
Source: Twist Bioscience Corporation
- 02
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
Source: Twist Bioscience Corporation
- 03
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
Source: Twist Bioscience Corporation
- 04
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
Source: Twist Bioscience Corporation
- 05
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
Source: Twist Bioscience Corporation
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Twist Bioscience Corporation (TWST)?
Twist Bioscience Corporation (TWST) most recently closed at 85.00 USD, a -0.20% move versus the previous session.
What is the market cap of Twist Bioscience Corporation (TWST)?
Twist Bioscience Corporation currently has a market capitalization of 5.29B USD on BioPharmSignal.
What does Twist Bioscience Corporation do?
Twist Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is TWST stock listed?
Twist Bioscience Corporation (TWST) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Twist Bioscience is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Twist?
Twist Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Twist Bioscience Corporation targeting with Twist?
Twist Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Bioscience?
Twist Bioscience is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.